Drug Companies “Apathetic” About Testing GLP-1 Drugs to Treat Substance Use Disorders
Early studies of GLP-1 drugs for substance abuse treatment show promise, but drug companies are slow to fund research.
New DNA Test Predicts Susceptibility to Opioid Addiction
The U.S. Food and Drug Administration has approved the use of a new DNA test to identify patients at risk of opioid use disorder.
Buprenorphine As an Emergency Treatment for Opioid Overdose
Training and equipping emergency medical personnel to administer buprenorphine is a money saver and a lifesaver.
Weight Loss and the Science of Habit Formation
A look at the way habit formation influences weight loss, eating addiction and other compulsive behaviors.
A More Humane, More Effective, and Less Expensive Way to Deal With Drug Addiction
Why are deaths due to overdose 10 times higher in the U.S. than the E.U.?
Contingency Management: Good Medicine That’s Hard to Swallow
Contingency management — the practice of paying small rewards for performance — is generating big rewards for recovery programs.